edited by W. H. Taliaferro, Division of Biological and Medical Research, Argonne National Laboratory, Argonne, Illinois, and J. H. Humphrey, National Institute of Medical Research, London, England. Vol. 1, x + 423 pages, illustrated. New York, London, Academic Press. 1961. $12.00
V. Evaluation of Cross-Immunity against Type 1 Dengue Fever in Human Subjects Convalescent from Subclinical Natural Japanese Encephalitis Virus Infection and Vaccinated with 17D Strain Yellow Fever Vaccine
You have honored me by electing me to be president of the Society for the past year and I thank you. It has been an exciting time with a new secretary/treasurer Jonathan Ravdin, a new editor McWilson Warren, a new program chairman Thomas Monath, and our first year under professional management. With all these changes, the year has gone well.
I was surprised, but pleased, to find that I was not alone in the anxiety of fashioning a presidential address. Most past presidents have discussed their choice between a presentation on science or on issues of concern to our Society. In the past few years, many have tended to the latter. Although, initially, I was tempted to present a talk on science, and you can be assured that some of my younger colleagues urged me to do this, I believe it more in keeping with the needs of our Society and my role during the past year to do otherwise.